Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-17 Sale | 2024-09-19 8:02 pm | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 57,969 | $4.0393 | $234,155 | 5,982,582 (Indirect Direct) | View |
| 2024-06-05 Sale | 2024-06-07 6:34 pm | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 1,006 | $4 | $4,024 | 6,040,551 (Indirect Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:30 pm | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 56,910 | $3.845 | $218,819 | 6,836,490 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Exercise | 2024-02-02 9:30 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 173,467 | $0 | 6,836,490 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:30 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 448,000 | $0 | 6,836,490 (Direct) | View |
| 2023-03-01 Disposition | 2023-03-03 4:00 pm | N/A N/A | ABG Acquisition Corp. I | ABGI | Sommadossi Jean-Pierre Director | 32,500 | $0 | 0 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:33 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 1,249,000 | $0 | 1,249,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 378,033 | $0 | 378,033 (Direct) | View |
| 2021-06-28 Option Award | 2021-06-30 6:49 pm | N/A 2031-06-27 | Kezar Life Sciences Inc. | KZR | Sommadossi Jean-Pierre Director | 26,000 | $0 | 26,000 (Direct) | View |
Ownership | 2021-02-16 9:59 pm | N/A N/A | ABG Acquisition Corp. I | ABGI | Sommadossi Jean-Pierre Director | 0 | $0 | 32,500 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:56 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 640,000 | $0 | 640,000 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:08 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 750,000 | $0 | 5,925,000 (Indirect) | View |
Ownership | 2020-10-29 8:45 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre JPM Partners LLC President, CEO, and Chairman 10% Owner | 0 | $0 | 7,110,000 (Indirect) | View |
| 2020-06-24 Option Award | 2020-06-26 5:09 pm | N/A 2030-06-23 | Kezar Life Sciences Inc. | KZR | Sommadossi Jean-Pierre Director | 8,896 | $0 | 8,896 (Direct) | View |